SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-17-003702
Filing Date
2017-03-03
Accepted
2017-03-02 18:37:39
Documents
101
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acrx20161231_10k.htm 10-K 2715842
2 EXHIBIT 10.43 ex10-43.htm EX-10.43 401371
3 EXHIBIT 21.2 ex21-2.htm EX-21.2 1539
4 EXHIBIT 23.1 ex23-1.htm EX-23.1 10550
5 EXHIBIT 23.2 ex23-2.htm EX-23.2 5664
6 EXHIBIT 31.1 ex31-1.htm EX-31.1 11042
7 EXHIBIT 31.2 ex31-2.htm EX-31.2 10876
8 EXHIBIT 32.1 ex32-1.htm EX-32.1 7091
15 acrx20161231_10kimg006.gif GRAPHIC 10836
16 acrx20161231_10kimg005.jpg GRAPHIC 15225
17 zalvisoimage.jpg GRAPHIC 4995
18 dsuviaimage.jpg GRAPHIC 9240
19 acrx20161231_10kimg002.jpg GRAPHIC 4257
20 acrx20161231_10kimg001.gif GRAPHIC 20256
  Complete submission text file 0001437749-17-003702.txt   10517411

Data Files

Seq Description Document Type Size
9 EXHIBIT 101.INS acrx-20161231.xml EX-101.INS 2013020
10 EXHIBIT 101.SCH acrx-20161231.xsd EX-101.SCH 96189
11 EXHIBIT 101.CAL acrx-20161231_cal.xml EX-101.CAL 53150
12 EXHIBIT 101.DEF acrx-20161231_def.xml EX-101.DEF 579149
13 EXHIBIT 101.LAB acrx-20161231_lab.xml EX-101.LAB 502814
14 EXHIBIT 101.PRE acrx-20161231_pre.xml EX-101.PRE 613628
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35068 | Film No.: 17660780
SIC: 2834 Pharmaceutical Preparations